Who will benefit from the more accurate measurement of RBC deformability and CSS?

Ultimately, anyone at risk of developing circulatory disorders will benefit from better technology for measuring cell deformability and critical shear stress. Quick and easy measurements at the point of care will provide earlier detection of the circulatory diseases including diabetic kidney disease and diabetic retinopathy , allowing patients to be treated on time and to have healthy life.

3 views0 comments

Recent Posts

See All

Does RheoScan receive any approval ?

RheoScan received approval from Korea Food & Drug Administration(KFDA) though GMP tests as a First class medical device in Dec., 2005. Furthermore, RheoScan have declared CE for high quality manufactu

Platelet function test - RheoMeditech


RheoMeditech Inc.,

32 Anam-ro, 2F


Seoul, Korea 02578

Tel: +82-2-537-5111

Fax: +82-2-537-5103

Copyright 2020 © RheoMeditech Inc. All Rights Reserved